Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
263.71B
Market cap263.71B
Price-Earnings ratio
15.73
Price-Earnings ratio15.73
Dividend yield
2.15%
Dividend yield2.15%
Average volume
13.65M
Average volume13.65M
High today
$59.15
High today$59.15
Low today
$57.36
Low today$57.36
Open price
$57.74
Open price$57.74
Volume
8.17M
Volume8.17M
52 Week high
$135.20
52 Week high$135.20
52 Week low
$45.05
52 Week low$45.05

NVO News

CNBC 2h
Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial

Key Points Eli Lilly said its experimental pill outperformed Novo Nordisk's own oral drug in the first head-to-head study comparing the two medicines in patient...

Eli Lilly’s obesity pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
TipRanks 6h
Novo Nordisk upgraded to Buy from Hold at Berenberg

Berenberg upgraded Novo Nordisk (NVO) to Buy from Hold with a price target of DKK 425, down from DKK 610. The firm says Novo is now its preferred obesity play....

Seeking Alpha 19h
Eli Lilly, Novo Nordisk rebuked by FDA for claims made in Oprah weight loss video

The U.S. FDA has issued separate warning letters to Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) regarding claims made about their obesity drugs in an Oprah Winf...

Eli Lilly, Novo Nordisk rebuked by FDA for claims made in Oprah weight loss video

Analyst ratings

56%

of 32 ratings
Buy
56.3%
Hold
40.6%
Sell
3.1%

More NVO News

Benzinga 23h
Stock Of The Day: Is The Novo Nordisk Death Spiral Finally Over?

Zinger Key Points Since June 2024, Novo Nordisk has lost about 60% of its value. But there is a chance that a reversal may be taking place. If buyers overpower...

Stock Of The Day: Is The Novo Nordisk Death Spiral Finally Over?
TipRanks 23h
FDA sends Novo Nordisk warning letter over weight loss video

The FDA posted a warning letter sent to Novo Nordisk (NVO) over a weight loss video the agency deems “false or misleading.” The letter states, “The video misbra...

Sherwood News 24h
Hims falls after FDA posts warning letter

The agency’s letter took issue with the claims made in Hims’ marketing materials. Hims & Hers fell by more than 5% after the US Food and Drug Administration po...

Hims falls after FDA posts warning letter
Benzinga 1d
Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment

Novo Nordisk A/S NVO reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (sema...

Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment
TipRanks 1d
Eli Lilly Falls as Novo Nordisk’s U.S. Survey Shows Its Drug Drowns ‘Food Noise’

Danish drugmaker Novo Nordisk (NVO) said its new survey in the U.S. shows that its weight loss drug, Wegovy, helps to douse “food noise” among 46% of users who...

TipRanks 1d
Novo Nordisk reports cagrilintide provided average weight reduction of 11.8%

Novo Nordisk (NVO) presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes congress 2025 from 1...

TipRanks 1d
Novo Nordisk to seek U.S. approval for high-dose obesity shot, Bloomberg reports

Novo Nordisk (NVO) Chief Scientific Officer Martin Holst Lange said on Tuesday at the European Association for the Study of Diabetes conference in Vienna that t...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.